Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 22 min 47 sec ago

Ivera Medical Announces Extension of Novation Agreement

Wed, 06/11/2014 - 12:12
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical Corporation, a certified minority-owned business, announced an extension of its agreement with Novation for the Curos® family of products. The agreement, which originally commenced o...
Devices, Group Purchasing
Ivera Medical, Novation , Curos Port Protectors, Curos Strips, Curos Tips

Bioventus Announces U.S. Debut of Feature-Rich New EXOGEN(R) Device

Tue, 06/10/2014 - 15:30
DURHAM, N.C.--(Healthcare Sales & Marketing Network)--Bioventus, a global leader in active orthopaedic healing, today rolled out the next generation of its market-leading1EXOGEN® Ultrasound Bone Healing System, which includes a variety of new complianc...
Devices, Orthopaedic, Product Launch
Bioventus, EXOGEN , Ultrasound Bone Healing System

Auxogyn Receives FDA Clearance for Its Eeva(TM) System

Tue, 06/10/2014 - 14:52
Breakthrough Test Provides First-of-a-Kind Objective Assessment of Embryo Development Potential MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Auxogyn, Inc. a leader in women’s reproductive health, today announced that its first product, th...
Devices, FDA
Auxogyn, Eeva System, in vitro fertilization

Pulsar Vascular Receives FDA IDE Approval for the PulseRider(R) Aneurysm Neck Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms

Tue, 06/10/2014 - 14:45
SAN JOSE, Calif., June 10, 2014 -- (Healthcare Sales & Marketing Network) -- Pulsar Vascular, the innovator and developer of the PulseRider®, a minimally invasive, aneurysm neck reconstruction device, announced today the United States Food and Drug Ad...
Devices, Interventional, FDA
Pulsar Vascular, PulseRider, bifurcation, aneurysm

Cohera Medical, Inc.(R)'s TissuGlu(R) Surgical Adhesive Advances to Food and Drug Administration Advisory Panel Meeting

Tue, 06/10/2014 - 14:37
PITTSBURGH, June 10, 2014 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received notice from the U.S. Food and Drug Admi...
Devices, Surgery, FDA
Cohera Medical, TissuGlu, Surgical Adhesive

Ivera Medical Asserts New Patent Litigation Against Competitors

Tue, 06/10/2014 - 14:33
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical Corporation, a certified minority-owned business, announced it has filed patent infringement lawsuits against its competitors in federal court in San Diego. U.S. Patent No. 8,740,864, is...
Devices, Litigation
Ivera Medical, Curos, Port Protector

Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine

Tue, 06/10/2014 - 10:56
Migraine Sufferers Achieved Greater Rates of Pain Relief and Pain Freedom Within 30 Minutes with AVP-825 Treatment Compared with Oral Sumatriptan Treatment ALISO VIEJO, Calif., June 10, 2014 -- (Healthcare Sales & Marketing Network) -- Avanir Pharmaceu...
Biopharmaceuticals
Avanir Pharmaceuticals, AVP-825, COMPASS study, migraine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong